CN112220892A - Plant nitric oxide supply and preparation method and application thereof - Google Patents

Plant nitric oxide supply and preparation method and application thereof Download PDF

Info

Publication number
CN112220892A
CN112220892A CN202011173402.3A CN202011173402A CN112220892A CN 112220892 A CN112220892 A CN 112220892A CN 202011173402 A CN202011173402 A CN 202011173402A CN 112220892 A CN112220892 A CN 112220892A
Authority
CN
China
Prior art keywords
parts
extract
nitric oxide
oxide donor
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011173402.3A
Other languages
Chinese (zh)
Inventor
张妍
郭长江
罗红梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou En Eu Biotechnology Co ltd
Original Assignee
Zhengzhou En Eu Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou En Eu Biotechnology Co ltd filed Critical Zhengzhou En Eu Biotechnology Co ltd
Priority to CN202011173402.3A priority Critical patent/CN112220892A/en
Publication of CN112220892A publication Critical patent/CN112220892A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3637Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a plant nitric oxide donor and a preparation method and application thereof, wherein the formula raw materials of the nitric oxide donor comprise, by mass, 10-20 parts of black fungus extract, 10-20 parts of mushroom extract, 20-30 parts of honey extract, 10-20 parts of Chinese date extract, 10-20 parts of eggplant extract, 10-20 parts of tomato extract, 10-20 parts of sweet potato extract, 10-20 parts of corn extract and 10-20 parts of onion extract. The invention adopts the freeze-drying method and the tape casting film forming method to prepare fibrous, film-shaped or porous materials, is used for preparing artificial blood vessels, vascular stents or wound dressings, has the characteristics of resisting platelet adhesion, promoting the growth of vascular endothelial cells and inhibiting the growth of smooth muscle cells, and can be used for the treatment of cardiovascular diseases and the effect of skin repair.

Description

Plant nitric oxide supply and preparation method and application thereof
Technical Field
The invention relates to the technical field of nitric oxide donors, in particular to a plant nitric oxide donor, and a preparation method and application thereof.
Background
The key to the project is the application of natural nitric oxide donor transformation in vivo to supplement nitric oxide to prevent and treat cardiovascular diseases including hypertension, the nitric oxide exists widely in vivo, but due to short half-life (only a few milliseconds) and extreme instability, continuous supplement is needed to meet the normal physiological needs of the body and maintain health, and the nitric oxide is sourced from endogenous synthesis and exogenous supplement.
Endogenous synthesis takes arginine, oxygen and NADPH as substrates, and nitric oxide and citrulline are catalytically generated by Nitric Oxide Synthase (NOS). Although a healthy human body has sufficient nitric oxide synthase to produce nitric oxide, the total activity of nitric oxide synthase in the human body is reduced with age due to various factors such as the reduction of gene expression in cell aging, and the production of nitric oxide in the human body is also reduced accordingly. For example, by the age of forty, nitric oxide is generated in healthy people, which is half or less than that of twenty years old, and causes dysfunction of vascular endothelial cells, and white blood cells and platelets are gathered on the vascular wall to cause atherosclerosis of the vascular wall. This may also explain why blood pressure rises with age. More importantly, the modern life has many factors to influence the nitric oxide, such as chronic diseases, smoking, air pollution, unhealthy diet, bad living habits, over-pressure and the like, which can directly or indirectly cause the reduction of the nitric oxide in the body.
Exogenous supplementation can be converted to nitric oxide in vivo by ingestion of food and drug nitric oxide donors. Clinically, commonly used nitrate-based drugs for treating angina pectoris and heart failure, such as nitroglycerin and Xiaocardia pain, expand blood vessels by supplying exogenous nitric oxide to vascular smooth muscle, relieve coronary spasm, increase blood volume in ischemic region, and reduce oxygen consumption of myocardium, so as to relieve symptoms of angina pectoris and heart failure. Nitrate drugs such as glycerol trinitrate can only temporarily relieve angina pectoris symptoms of coronary heart disease, cannot delay the progress of the disease course, and have no improvement effect on prognosis. Meanwhile, the medicine for supplementing nitric oxide is usually only used for emergency due to large dosage, quick response and short duration
The nitric oxide donors are quick to absorb (1-2 minutes of action), short in drug effect (the half-life period is only 7 minutes), and capable of effectively relieving cardiovascular pressure, but because nitric oxide is quickly released in a large amount to cause vascular irritation and relaxation, the common clinical side effects such as headache, palpitation, hypotension, syncope and the like are caused, drug resistance is generated after long-term large-amount administration, and therefore, the drug supplementing nitric oxide cannot be used as a conventional nitric oxide supplementing way.
Disclosure of Invention
The invention aims to provide a plant nitric oxide supply and a preparation method and application thereof.
The above object of the present invention is achieved by the following technical solutions:
the plant nitric oxide donor is characterized in that the formula raw materials of the nitric oxide donor comprise, by mass, 10-20 parts of black fungus extract, 10-20 parts of mushroom extract, 20-30 parts of honey extract, 10-20 parts of Chinese date extract, 10-20 parts of eggplant extract, 10-20 parts of tomato extract, 10-20 parts of sweet potato extract, 10-20 parts of corn extract and 10-20 parts of onion extract.
Preferably, the nitric oxide donor formula raw materials comprise, by mass, 10 parts of black fungus extract, 10 parts of mushroom extract, 20 parts of honey extract, 10 parts of Chinese date extract, 10 parts of eggplant extract, 10 parts of tomato extract, 10 parts of sweet potato extract, 10 parts of corn extract and 10 parts of onion extract.
Preferably, the nitric oxide donor formula raw materials comprise, by mass, 20 parts of black fungus extract, 20 parts of mushroom extract, 30 parts of honey extract, 20 parts of Chinese date extract, 20 parts of eggplant extract, 20 parts of tomato extract, 20 parts of sweet potato extract, 20 parts of corn extract and 20 parts of onion extract.
Preferably, the nitric oxide donor formula raw materials comprise, by mass, 15 parts of black fungus extract, 15 parts of mushroom extract, 25 parts of honey extract, 15 parts of Chinese date extract, 15 parts of eggplant extract, 15 parts of tomato extract, 15 parts of sweet potato extract, 15 parts of corn extract and 15 parts of onion extract.
A preparation method of a plant nitric oxide donor comprises the following preparation steps:
step 1: putting black fungus, mushroom, Chinese date, eggplant, tomato, sweet potato, corn and onion into a grinding tank for grinding treatment, and grinding into powder;
step 2: putting the powder obtained in the step 1 into a centrifuge, adding honey and the extract, centrifuging by a relative centrifugal force of below 5000g for 10-15 min, taking out the upper-layer mixed solution, centrifuging for the second time, repeating the step for 5 times, and collecting the upper-layer mixed solution;
and step 3: and (3) carrying out spray drying on the mixed solution finally obtained in the step (2) to obtain the nitric oxide donor.
The application of the plant nitric oxide donor in the wound healing dressing is to blend and compound the plant nitric oxide donor and a polymer, prepare a fibrous, membranous or porous material by adopting a freeze drying method and a tape casting film forming method, and use the fibrous, membranous or porous material in the preparation of artificial blood vessels, vascular stents or wound dressings.
In conclusion, the beneficial technical effects of the invention are as follows:
1. the nitric oxide donor can be applied to preparing artificial blood vessels or blood vessel stents, wound dressings and the like. The plant nitric oxide donor and the polymer can be blended and compounded, and prepared into fibrous, film-shaped or porous materials by adopting an electrostatic spinning method, a freeze-drying method, a casting film forming method and the like, and the materials are used for artificial blood vessels, vascular stents, wound dressings and the like, for example, the nitric oxide donor and the polymer can be blended and compounded to prepare films or coatings; or blending with other polymers, casting to form a film, and particularly, can be used for preparing materials such as artificial blood vessels, vascular stents, wound dressings and the like;
2. can be easily compounded with other materials to prepare biomedical materials, has the characteristics of resisting platelet adhesion, promoting the growth of endothelial cells in blood vessels and inhibiting the growth of smooth muscle cells, and can be used for treating cardiovascular diseases, repairing skin and the like.
Detailed Description
The present invention will be described in further detail with reference to examples.
Example 1
The invention discloses a plant nitric oxide donor, which comprises the following raw materials, by mass, 10 parts of black fungus extract, 10 parts of mushroom extract, 20 parts of honey extract, 10 parts of Chinese date extract, 10 parts of eggplant extract, 10 parts of tomato extract, 10 parts of sweet potato extract, 10 parts of corn extract and 10 parts of onion extract.
Example 2
The invention discloses a plant nitric oxide donor, which comprises the following raw materials, by mass, 20 parts of black fungus extract, 20 parts of mushroom extract, 30 parts of honey extract, 20 parts of Chinese date extract, 20 parts of eggplant extract, 20 parts of tomato extract, 20 parts of sweet potato extract, 20 parts of corn extract and 20 parts of onion extract.
Example 3
The invention discloses a plant nitric oxide donor, which comprises the following raw materials, by mass, 15 parts of black fungus extract, 15 parts of mushroom extract, 25 parts of honey extract, 15 parts of Chinese date extract, 15 parts of eggplant extract, 15 parts of tomato extract, 15 parts of sweet potato extract, 15 parts of corn extract and 15 parts of onion extract.
A preparation method of a plant nitric oxide donor comprises the following preparation steps:
step 1: putting black fungus, mushroom, Chinese date, eggplant, tomato, sweet potato, corn and onion into a grinding tank for grinding treatment, and grinding into powder;
step 2: putting the powder obtained in the step 1 into a centrifuge, adding honey and the extract, centrifuging by a relative centrifugal force of below 5000g for 10-15 min, taking out the upper-layer mixed solution, centrifuging for the second time, repeating the step for 5 times, and collecting the upper-layer mixed solution;
and step 3: and (3) carrying out spray drying on the mixed solution finally obtained in the step (2) to obtain the nitric oxide donor.
The application of the plant nitric oxide donor in the wound healing dressing is to blend and compound the plant nitric oxide donor and a polymer, prepare a fibrous, membranous or porous material by adopting a freeze drying method and a tape casting film forming method, and use the fibrous, membranous or porous material in the preparation of artificial blood vessels, vascular stents or wound dressings. .
The implementation principle of the embodiment is as follows: the nitric oxide donor can be applied to preparing artificial blood vessels or blood vessel stents, wound dressings and the like. The plant nitric oxide donor and the polymer can be blended and compounded, and prepared into fibrous, film-shaped or porous materials by adopting an electrostatic spinning method, a freeze-drying method, a casting film forming method and the like, and the materials are used for artificial blood vessels, vascular stents, wound dressings and the like, for example, the nitric oxide donor and the polymer can be blended and compounded to prepare films or coatings; or blending with other polymers, casting to form a film, and particularly, can be used for preparing materials such as artificial blood vessels, vascular stents, wound dressings and the like; can be easily compounded with other materials to prepare biomedical materials, has the characteristics of resisting platelet adhesion, promoting the growth of endothelial cells in blood vessels and inhibiting the growth of smooth muscle cells, and can be used for treating cardiovascular diseases, repairing skin and the like.
The embodiments of the present invention are preferred embodiments of the present invention, and the scope of the present invention is not limited by these embodiments, so: all equivalent changes made according to the structure, shape and principle of the invention are covered by the protection scope of the invention.

Claims (6)

1. The plant nitric oxide donor is characterized in that the formula raw materials of the nitric oxide donor comprise, by mass, 10-20 parts of black fungus extract, 10-20 parts of mushroom extract, 20-30 parts of honey extract, 10-20 parts of Chinese date extract, 10-20 parts of eggplant extract, 10-20 parts of tomato extract, 10-20 parts of sweet potato extract, 10-20 parts of corn extract and 10-20 parts of onion extract.
2. The plant nitric oxide donor according to claim 1, wherein the nitric oxide donor formula comprises, by mass, 10 parts of black fungus extract, 10 parts of mushroom extract, 20 parts of honey extract, 10 parts of jujube extract, 10 parts of eggplant extract, 10 parts of tomato extract, 10 parts of sweet potato extract, 10 parts of corn extract and 10 parts of onion extract.
3. The plant nitric oxide donor according to claim 1, wherein the nitric oxide donor formula comprises, by mass, 20 parts of black fungus extract, 20 parts of mushroom extract, 30 parts of honey extract, 20 parts of jujube extract, 20 parts of eggplant extract, 20 parts of tomato extract, 20 parts of sweet potato extract, 20 parts of corn extract and 20 parts of onion extract.
4. The plant nitric oxide donor according to claim 1, wherein the nitric oxide donor formula comprises, by mass, 15 parts of black fungus extract, 15 parts of mushroom extract, 25 parts of honey extract, 15 parts of jujube extract, 15 parts of eggplant extract, 15 parts of tomato extract, 15 parts of sweet potato extract, 15 parts of corn extract and 15 parts of onion extract.
5. The method of claim 1, comprising the steps of:
step 1: putting black fungus, mushroom, Chinese date, eggplant, tomato, sweet potato, corn and onion into a grinding tank for grinding treatment, and grinding into powder;
step 2: putting the powder obtained in the step 1 into a centrifuge, adding honey and the extract, centrifuging by a relative centrifugal force of below 5000g for 10-15 min, taking out the upper-layer mixed solution, centrifuging for the second time, repeating the step for 5 times, and collecting the upper-layer mixed solution;
and step 3: and (3) carrying out spray drying on the mixed solution finally obtained in the step (2) to obtain the nitric oxide donor.
6. The application of the plant nitric oxide donor in the wound healing dressing according to claim 1, wherein the plant nitric oxide donor and the polymer are blended and compounded, and the mixture is prepared into a fibrous, film-shaped or porous material by adopting a freeze drying method and a casting film forming method, and is used for preparing an artificial blood vessel, a blood vessel stent or a wound dressing.
CN202011173402.3A 2020-10-28 2020-10-28 Plant nitric oxide supply and preparation method and application thereof Pending CN112220892A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011173402.3A CN112220892A (en) 2020-10-28 2020-10-28 Plant nitric oxide supply and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011173402.3A CN112220892A (en) 2020-10-28 2020-10-28 Plant nitric oxide supply and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN112220892A true CN112220892A (en) 2021-01-15

Family

ID=74110074

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011173402.3A Pending CN112220892A (en) 2020-10-28 2020-10-28 Plant nitric oxide supply and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN112220892A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110522787A (en) * 2018-05-24 2019-12-03 郑州恩欧生物科技有限公司 Nitric oxide donors compound Chinese medicinal preparation and its preparation method and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110522787A (en) * 2018-05-24 2019-12-03 郑州恩欧生物科技有限公司 Nitric oxide donors compound Chinese medicinal preparation and its preparation method and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KUANXINJIE: "在食物中获得一氧化氮(上)", 《网络公开HTTP://WWW.360DOC.COM/CONTENT/12/11114/14/1132158_247799874.SHTML》 *
邢叔星等: "一氧化氮在创伤伤口愈合中的作用研究进展", 《创伤外科杂志》 *

Similar Documents

Publication Publication Date Title
Yasin et al. Advances in hyaluronic acid for biomedical applications
WO2021143951A2 (en) Colchicine soluble microneedle patch and preparation method therefor
AU2020101591A4 (en) A thermosensitive gel, preparation method and application thereof
CN111110623A (en) Self-repairing small needle nutrient solution formula
CN112716930A (en) Application of kaurane compounds in preparing medicine for inhibiting pathological fibrosis and remodeling of tissues and organs
KR100828494B1 (en) A composition of a cosmetic essense and the method of prepating it for improvenent of wrinkle
CN102970972A (en) Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
CN107441547B (en) Wound repair material and preparation method and application thereof
CN104719874A (en) Ganoderma lucidum full-ingredient mixed chewable tablets and preparation method thereof
CN114699513A (en) Preparation method of scar gel containing yeast recombinant collagen
CN112220892A (en) Plant nitric oxide supply and preparation method and application thereof
US20050187185A1 (en) Pharmaceutical applications of hyaluronic acid preparations
CN109985271A (en) A kind of composite collagen dressing and preparation method thereof for refractory conjunction wound repair
JPH02121922A (en) Usage of ace inhibitor
JP2019532037A (en) Composition for partial obesity treatment and microneedle containing the same
CN106562953B (en) Application, drug and process for preparing medicine of the hydroxyl radical carthamin yellow carthamus A in the drug of preparation treatment diabetic foot ulcer
Carlson et al. Clinical, metabolic and cardiovascular effects of different prostaglandins in man
Eisenberg et al. The effect of castration and of testosterone upon the respiration of rat brain
CN102266595A (en) Medicament coating titanium nail using chitosan gelatin as carrier
CN111920827B (en) Preparation method of compound slow-release nanoparticle for promoting tissue healing
CN108785128A (en) A kind of Hydrolyzed Collagen liposome and preparation method thereof of polypropylene glycol modification
KR102178353B1 (en) patch composition for diabetes mellitus and patch manufacturing method using the same
CN112546101A (en) Traditional Chinese medicine compound for relieving eczema, sustained-release agent, preparation method and application
KR102588877B1 (en) Injection liquid composition for localized lipolysis and Administration method of the same
CN117244027B (en) A pharmaceutical composition for treating cardiovascular diseases, and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210115